NPM1 (MutA,B,C&D) Mutation Detection Kit
£1,333.00
The geneMAP™ NPM1 (MutA, B, C & D) Mutation Detection Kit is an advanced diagnostic tool crafted for the rapid and sensitive detection of the four most common mutations (MutA, B, C, and D) in the NPM1 gene, utilizing allele-specific PCR and multiplex real-time PCR technology. Designed for compatibility with FAM and VIC/HEX two-color real-time PCR instruments and CE-IVD certified, this kit is pivotal in the diagnosis and prognosis of acute myeloid leukemia (AML), where NPM1 mutations play a crucial role in identifying patients likely to benefit from chemotherapy.
The geneMAP™ NPM1 (MutA, B, C & D) Mutation Detection Kit is an advanced diagnostic tool crafted for the rapid and sensitive detection of the four most common mutations (MutA, B, C, and D) in the NPM1 gene, utilizing allele-specific PCR and multiplex real-time PCR technology. Designed for compatibility with FAM and VIC/HEX two-color real-time PCR instruments and CE-IVD certified, this kit is pivotal in the diagnosis and prognosis of acute myeloid leukemia (AML), where NPM1 mutations play a crucial role in identifying patients likely to benefit from chemotherapy.
- Allele Specific PCR: Ensures high specificity and sensitivity in detecting NPM1 mutations (MutA, B, C, and D).
- Multiplex Real-time PCR Technology: Enables fast and efficient analysis of multiple NPM1 mutations, facilitating timely clinical decision-making.
- Instrument Compatibility: Works seamlessly with FAM and VIC/HEX two-color real-time PCR instruments, providing flexibility in laboratory use.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, affirming the kit’s reliability and quality.
- Accurate Mutation Detection: Offers precise identification of NPM1 mutations, crucial for determining the prognosis and guiding treatment strategies in AML patients.
- Rapid and User-Friendly: Designed for ease of use, the kit allows for quick and efficient screening of NPM1 mutations, aiding in the prompt initiation of appropriate therapy.
- Comprehensive Analysis: With the capability to detect the four most common NPM1 mutations, this kit provides a comprehensive approach to understanding the genetic landscape of AML patients.
- Diagnosis and Prognosis of AML: Essential for identifying AML patients with NPM1 mutations (MutA, B, C, and D), informing prognosis and tailoring treatment approaches based on genetic findings.
- Mutation Coverage: Targets the four most prevalent mutations on the NPM1 gene (MutA, B, C, and D), addressing the most clinically significant variations.
- Technology: Utilizes allele-specific and multiplex real-time PCR for efficient and accurate mutation detection.
- Compatibility: Compatible with FAM and VIC/HEX two-color real-time PCR instruments.
- Certification: Carries the CE-IVD mark, indicating compliance with EU regulations for in vitro diagnostic use.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
